|
1.
|
Notifying
Member: EUROPEAN UNION
If applicable, name of local government involved (Articles 3.2 and 7.2):
|
|
2.
|
Agency
responsible:
European
Commission
EU-TBT
Enquiry Point,
Fax: +(32) 2
299 80 43,
E-mail: grow-eu-tbt@ec.europa.eu
Website:
https://technical-barriers-trade.ec.europa.eu/en/home
|
|
3.
|
Notified
under Article 2.9.2 [X], 2.10.1 [ ], 5.6.2 [ ], 5.7.1 [ ], 3.2 [ ], 7.2 [ ], Other:
|
|
4.
|
Products covered (HS codes or national tariff lines. ICS numbers may
be provided in addition, where applicable): Medical devices
and in vitro diagnostic medical
devices
|
|
5.
|
Details of notified document(s) (title,
number of pages and languages, means of access): Draft Commission Implementing Regulation
laying down certain uniform quality management and procedural requirements
for the conformity assessment activities carried out by a notified body
designated under Regulations (EU) 2017/745 and (EU) 2017/746 of the European
Parliament and of the Council; (13 page(s), in English)
Link to notified document(s) and/or contact
details for agency or authority which can provide copies upon request:
European Commission
EU-TBT Enquiry Point
Fax: + (32) 2 299 80 43
E-mail: grow-eu-tbt@ec.europa.eu
The text is available on the Website: https://technical-barriers-trade.ec.europa.eu/en/home
|
|
6.
|
Description
of content: The notified draft sets
out requirements for the harmonised applications of provisions for notified
bodies established in Annex VII to Regulations (EU) 2017/745 on medical
devices and (EU) 2017/746 on in vitro diagnostics. In particular, those
provisions cover quotations, timelines for notified bodies to carry out
conformity assessment activities, monitoring of notified bodies' performances
as regards timelines and costs and re-certification.
|
|
7.
|
Objective
and rationale, including the nature of urgent problems where applicable: The notified draft aims at resolving issues of diverging
interpretations and practical application of certain requirements for
notified bodies set out in Annex VII to Regulations (EU) 2017/745 and (EU)
2017/746.; Harmonization
|
|
8.
|
Relevant
documents:
- Regulation
(EU) 2017/745 of the European Parliament and of the Council of 5 April 2017
on medical devices, amending Directive 2001/83/EC, Regulation (EC) No
178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives
90/385/EEC and 93/42/EEC (OJ L 117, 5.5.2017, p. 1).
EUR-Lex - 02017R0745-20200424 - EN - EUR-Lex
(europa.eu)
- Regulation
(EU) 2017/746 of the European Parliament and of the Council of 5 April 2017
on in vitro diagnostic medical
devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU
(OJ L 117 5.5.2017, p. 176).
EUR-Lex - 02017R0746-20170505 - EN - EUR-Lex
(europa.eu)
|
|
9.
|
Proposed
date of adoption: March 2026
Proposed date of entry into force: 20 days after its publication in the Official Journal of the
European Union
|
|
10.
|
Provision of comments
Final
date for comments: 20 February 2026
[X] 60 days from notification
Contact details of agency or authority designated to handle comments
regarding the notification:
European
Commission,
EU-TBT
Enquiry Point,
Fax: +
(32) 2 299 80 43,
E-mail: grow-eu-tbt@ec.europa.eu
|